Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma

Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma

Laryngeal squamous cell carcinoma (LSCC) remains a highly morbid and fatal disease. Historically, it has been a model example for organ preservation and treatment stratification paradigms. Unfortunately, survival for LSCC has stagnated over the past few decades. As the era of next-generation sequenc...

Full description

Bibliographic Details
Main Authors: Megan L. Ludwig, Andrew C. Birkeland, Rebecca Hoesli, Paul Swiecicki, Matthew E. Spector, J. Chad Brenner
Format: Article
Language:English
Published: China Anti-Cancer Association 2016-03-01
Series:Cancer Biology & Medicine
Subjects:
Head and neck cancer
laryngeal squamous cell carcinoma
genetics
targeted therapy
personalized medicine
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/911

Internet

http://www.cancerbiomed.org/index.php/cocr/article/view/911

Similar Items